The role of SMARCB1/INI1 in development of rhabdoid tumor

被引:152
作者
Roberts, Charles W. M. [3 ]
Biegel, Jaclyn A. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[3] Harvard Univ, Childrens Hosp, Dept Pediat Oncol, Dana Farber Canc Inst,Sch Med,Div Hematol Oncol, Boston, MA 02115 USA
关键词
rhabdoid tumor; retroperitoneum; angiogenesis; surgery; chemotherapy; radiotherapy; targeted therapy; recurrence; metastasis; CHROMATIN-REMODELING COMPLEX; ATYPICAL TERATOID/RHABDOID TUMORS; STRAND BREAK REPAIR; CELL-CYCLE ARREST; DNA-DAMAGE; SUPPRESSOR GENE; HSNF5/INI1; GENE; IMMUNOHISTOCHEMICAL ANALYSIS; MOLECULAR CHARACTERIZATION; FAMILIAL SCHWANNOMATOSIS;
D O I
10.4161/cbt.8.5.8019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A note about nomenclature: The ortholog of the gene mutated in rhabdoid tumors was first studied in yeast where it was identified in a screen for mutants incapable of fermenting sucrose. It was thus given the name Sucrose Non-Fermenting gene number 5 (SNF5) and was subsequently found to be a member of the SWI/SNF chromatin remodeling complex. The human ortholog of the gene was identified in a screen for proteins capable of interacting with the integrase protein of the human immunodeficiency virus and was given the name INtegrase Interactor 1 (INI1). Investigators studying a mammalian version of the Swi/Snf complex felt that its function may have diverged somewhat from the yeast complex and thus proposed renaming the complex the Brg1/Brm Associated Factors complex, or BAF complex. The rhabdoid tumor gene was thus given the name BAF47 based upon its apparent molecular mass of 47 Kd. Most recently, the genetic nomenclature committee bestowed the name SMARCB1 for SWI/SNF related, Matrix associated, Actin dependent Regulator of Chromatin, subfamily B, member 1. Each of these names has been used extensively in the literature and we ourselves have referred to the gene as either SNF5 (CWMR) or INI1 (JAB). In an effort to simplify communication, we have chosen to use the official SMARCB1 nomenclature here.
引用
收藏
页码:412 / 416
页数:5
相关论文
共 50 条
  • [21] First Case of SMARCB1(INI1)- Deficient Squamous Cell Carcinoma of the Pleura
    Yoshida, Kazushi
    Fujiwara, Yutaka
    Shiraishi, Hideaki
    Goto, Keiko
    Tsuruoka, Kenjiro
    Itahashi, Kota
    Goto, Yasushi
    Horinouchi, Hidehito
    Kanda, Shintaro
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Tsuta, Koji
    Ohe, Yuichiro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S509 - S509
  • [22] The Expanding Family of SMARCB1(INI1)-deficient Neoplasia: Implications of Phenotypic, Biological, and Molecular Heterogeneity
    Agaimy, Abbas
    ADVANCES IN ANATOMIC PATHOLOGY, 2014, 21 (06) : 394 - 410
  • [23] Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors
    Pathak, Rajiv
    Zin, Francesca
    Thomas, Christian
    Bens, Susanne
    Gayden, Tenzin
    Karamchandani, Jason
    Dudley, Roy W.
    Nemes, Karolina
    Johann, Pascal D.
    Oyen, Florian
    Kordes, Uwe
    Jabado, Nada
    Siebert, Reiner
    Paulus, Werner
    Kool, Marcel
    Fruhwald, Michael C.
    Albrecht, Steffen
    Kalpana, Ganjam V.
    Hasselblatt, Martin
    ACTA NEUROPATHOLOGICA, 2021, 142 (02) : 361 - 374
  • [24] SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
    Righi, Alberto
    Cocchi, Stefania
    Maioli, Margherita
    Zoli, Matteo
    Guaraldi, Federica
    Carretta, Elisa
    Magagnoli, Giovanna
    Pasquini, Ernesto
    Melotti, Sofia
    Vornetti, Gianfranco
    Tonon, Caterina
    Mazzatenta, Diego
    Asioli, Sofia
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases
    Jo, Vickie Y.
    Fletcher, Christopher D. M.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (08) : 1013 - 1022
  • [26] Conventional Spinal Chordomas: Investigation of SMARCB1/INI1 Protein Expression, Genetic Alterations in SMARCB1 Gene, and Clinicopathological Features in 89 Patients
    Maioli, Margherita
    Cocchi, Stefania
    Gambarotti, Marco
    Benini, Stefania
    Magagnoli, Giovanna
    Gamberi, Gabriella
    Griffoni, Cristiana
    Gasbarrini, Alessandro
    Ghermandi, Riccardo
    Noli, Luigi Emanuele
    Alcherigi, Chiara
    Ferrari, Cristina
    Bianchi, Giuseppe
    Asioli, Sofia
    Pignotti, Elettra
    Righi, Alberto
    CANCERS, 2024, 16 (16)
  • [27] SMARCB1 (INI1) retained but SMARCA4 (BRG1) negative atypical teratoid/rhabdoid tumor arising at the bilateral cerebellopontine angles: a case report
    Mitsui, Nobuyuki
    Oikawa, Kensuke
    Tanino, Mishie
    Kinoshita, Manabu
    JOURNAL OF SURGICAL CASE REPORTS, 2021, 2021 (09):
  • [28] Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
    Kim, Kimberly H.
    Roberts, Charles W. M.
    CANCER GENETICS, 2014, 207 (09) : 365 - 372
  • [29] Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium
    Donner, Ludvik R.
    Wainwright, Luanne M.
    Zhang, Fan
    Biegel, Jadyn A.
    HUMAN PATHOLOGY, 2007, 38 (06) : 935 - 939
  • [30] The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report
    Yoshida, Kazushi
    Fujiwara, Yutaka
    Goto, Yasushi
    Kohno, Takashi
    Yoshida, Akihiko
    Tsuta, Koji
    Ohe, Yuichiro
    BMC CANCER, 2018, 18